| 叶胜捷张文振庞淑光方声教章锦成陈如俊△ 叶鹂柳.乌司他丁与沐舒坦治疗严重烧伤伴吸入性损伤的疗效分析*[J].现代生物医学进展英文版,2014,14(15):2906-2908. |
| 乌司他丁与沐舒坦治疗严重烧伤伴吸入性损伤的疗效分析* |
| Efficacy of High-dose Ulinastatin and Ambroxol Using for EarlyCombination of Severe Burns with Severe Inhalation Injury* |
| |
| DOI： |
| 中文关键词: 乌司他丁 沐舒坦 严重烧伤 疗效 |
| 英文关键词: Ulinastatin Mucosolvan Severe burns Efficacy |
| 基金项目:卫生部科技计划项目（W2012ZT72） |
|
| Hits: 713 |
| Download times: 936 |
| 中文摘要: |
| 摘要目的：探讨严重烧伤伴中重度吸入性损伤患者早期联合使用大剂量乌司他丁与沐舒坦的临床疗效。方法：选择2003 年5
月～2013年5 月在我院接受治疗的185 例严重烧伤伴中重度吸入性损伤患者，随机分为两组，治疗组93 例，对照组92 例。两组
患者在确诊为中重度吸入性损伤后，立即给予传统常规治疗：吸氧、视情尽早预防性气管切开、湿化气道及气道灌洗、翻身拍背吸
痰、呼吸机辅助呼吸等。治疗组在常规治疗的基础上给予乌司他丁40 万单位，每隔8h 静脉滴注，沐舒坦450 mg，每隔12h 微泵静
推；对照组给予乌司他丁10 万单位，每隔8h 静滴，沐舒坦30 mg，每隔8h 静滴，疗程为10 天，比较两组患者急性肺损伤（ALI）的
发生率、急性呼吸窘迫综合征（ARDS）的发生率、呼吸机使用时间、死亡率。结果：治疗组93 例患者，治愈92 例，死亡1例，死亡率
为1.08%（1/93），治疗过程中发生ALI34 例，ARDS12例，呼吸机使用时间为（4.2± 2.1）d。对照组92 例患者治愈88 例，死亡4 例，
死亡率率为4.35%（4/92），治疗过程中发生ALI43 例，ARDS17 例，呼吸机使用时间为（8.2± 2.7）d。两组患者ALI 发生率、ARDS
发生率、呼吸机使用时间、治愈率差异均有统计学意义（P<0.05）。结论：对于严重烧伤伴中重度吸入性损伤的患者，在气管切开的
前提下，给予常规传统治疗的同时，采用大剂量乌司他丁与沐舒坦早期联合使用给药，能够明显的提高治愈率，降低并发症，值得
在临床上广泛推广应用。 |
| 英文摘要: |
| ABSTRACT Objective:To investigate the clinical efficacy of large doses Ulinastatin with ambroxol using for severe burns with severe
inhalation injury in patients with early joint. Methods:185 cases of severe burns with severe inhalation injury from May 2003 to
May 2013 treated in our hospital were selected and randomly divided into two groups, the treatment group with 93 cases, 92 cases of the
control group. Both groups were diagnosed with moderate to severe inhalation injury, immediately given the traditional conventional
treatment: oxygen, depending on the situation as soon as possible preventive tracheotomy airway humidification and airway lavage, stand
back suction, ventilator-assisted breathing. Treatment group was given Ulinastatin 400,000 units every 8h intravenously Ambroxol
450mg, every 12h micropump bolus on the basis of the conventional treatment; control group were given ulinastatin 100,000 units every
8h infusion, ambroxol 30mg, every 8h intravenously, treatment for 10 days. Acute lung injury(ALI) the incidence of acute respiratory distress
syndrome (ARDS) the incidence of ventilator use of time, death rate were compared between the two groups of patients with.
Results:The treatment group, 93 patients were cured 92 cases, 1 patient died, the mortality rate was 1.08% (1/93), the course of treatment ALI34
cases, ARDS12 cases, mechanical ventilation time was (4.2 ± 2.1) d. Control group, 92 patients were cured 88 cases, 4 deaths, the mortality
rate was 4.35% (4/92), the course of treatment ALI43 cases, ARDS17 cases, mechanical ventilation time was (8.2 ± 2.7) d. Two
groups of patients the incidence of ALI, ARDS incidence of ventilator use of time, the cure rate differences were statistically significant
(P <0.05). Conclusion:For severe burns with severe inhalation injury patients, tracheotomy premise, given conventional treatment, giving
high-dose ulinastatin conjunction with ambroxol early could significantly improve the cure rate, reduce complications, so it was worth
widely used in clinical application. |
|
View Full Text
View/Add Comment Download reader |
| Close |
|
|
|
